This presentation was made by Thomas Baardseng, Norway, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Advanced technologies and budgetary implications -- Vadim Perman, IsraelOECD Governance
This presentation was made by Vadim Perman, Israel, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Advanced health technologies and budgetary implications -- Valerie Paris, OECDOECD Governance
This presentation was made by Valérie Paris, OECD Secretariat, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Productivity in the health sector -- Peter Smith, United KingdomOECD Governance
This presentation was made by Peter Smith, United Kingdom, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Saudi Arabia has the largest healthcare market in the GCC due to high population growth, aging population, and diseases related to lifestyle. The government spends over $28 billion annually on healthcare and aims to increase capacity and quality through privatization, insurance reforms, and regulatory changes. There are many investment opportunities in hospitals, medical cities, specialized care, diagnostics, manufacturing, insurance, education, e-health, and partnerships with international companies. The healthcare sector is moving from a national system to a more private and market-driven system to meet the growing demands of the population.
This document provides an overview of health technology assessment (HTA) through a presentation given at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean. It defines HTA and its goals of providing evidence-informed input to decision makers and ensuring value for money. The presentation outlines how HTA is a multidisciplinary activity that examines the effects of health technologies on resources, costs, technical aspects, and other issues. It provides examples of HTA implementation from Thailand, Iran, and other countries. The presentation calls for all countries to establish national HTA programs and capacities and emphasizes that HTA is especially important for resource-limited settings. It outlines future commitments and steps from member states and WHO to strengthen HTA in the
Early Warning And Reporting System (EWARS) in NepalPublic Health
The Early Warning and Reporting System (EWARS) is a hospital-based sentinel surveillance system in Nepal that monitors six priority infectious diseases. EWARS was established in 1997 with 8 sentinel sites and has since expanded to 118 sites including central, provincial, and district hospitals. The main objectives of EWARS are to strengthen disease information flow and facilitate prompt outbreak response. Sentinel sites report disease data weekly or immediately to the Epidemiology and Disease Control Division, which analyzes trends, provides feedback, and coordinates rapid response teams if an outbreak is detected.
This document summarizes work done by the Disease Control Priorities Project to develop packages of essential health interventions for universal health coverage. It discusses analyzing health systems in countries to understand gaps, and selecting interventions based on criteria like cost-effectiveness, equity, and feasibility. Two priority packages are outlined: intersectoral policies like taxes on unhealthy foods and behaviors to improve health, and healthcare services like cancer treatment and managing mental health conditions. Examples of highest priority interventions in each package are provided based on their potential health impact, cost-effectiveness, and ability to strengthen health systems and provide financial risk protection to populations.
Advanced technologies and budgetary implications -- Vadim Perman, IsraelOECD Governance
This presentation was made by Vadim Perman, Israel, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Advanced health technologies and budgetary implications -- Valerie Paris, OECDOECD Governance
This presentation was made by Valérie Paris, OECD Secretariat, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Productivity in the health sector -- Peter Smith, United KingdomOECD Governance
This presentation was made by Peter Smith, United Kingdom, at the 6th Meeting of the Joint OECD DELSA-GOV Network on Fiscal Sustainability of Health Systems, held at the OECD Conference Centre, Paris, on 18-19 September 2017
Saudi Arabia has the largest healthcare market in the GCC due to high population growth, aging population, and diseases related to lifestyle. The government spends over $28 billion annually on healthcare and aims to increase capacity and quality through privatization, insurance reforms, and regulatory changes. There are many investment opportunities in hospitals, medical cities, specialized care, diagnostics, manufacturing, insurance, education, e-health, and partnerships with international companies. The healthcare sector is moving from a national system to a more private and market-driven system to meet the growing demands of the population.
This document provides an overview of health technology assessment (HTA) through a presentation given at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean. It defines HTA and its goals of providing evidence-informed input to decision makers and ensuring value for money. The presentation outlines how HTA is a multidisciplinary activity that examines the effects of health technologies on resources, costs, technical aspects, and other issues. It provides examples of HTA implementation from Thailand, Iran, and other countries. The presentation calls for all countries to establish national HTA programs and capacities and emphasizes that HTA is especially important for resource-limited settings. It outlines future commitments and steps from member states and WHO to strengthen HTA in the
Early Warning And Reporting System (EWARS) in NepalPublic Health
The Early Warning and Reporting System (EWARS) is a hospital-based sentinel surveillance system in Nepal that monitors six priority infectious diseases. EWARS was established in 1997 with 8 sentinel sites and has since expanded to 118 sites including central, provincial, and district hospitals. The main objectives of EWARS are to strengthen disease information flow and facilitate prompt outbreak response. Sentinel sites report disease data weekly or immediately to the Epidemiology and Disease Control Division, which analyzes trends, provides feedback, and coordinates rapid response teams if an outbreak is detected.
This document summarizes work done by the Disease Control Priorities Project to develop packages of essential health interventions for universal health coverage. It discusses analyzing health systems in countries to understand gaps, and selecting interventions based on criteria like cost-effectiveness, equity, and feasibility. Two priority packages are outlined: intersectoral policies like taxes on unhealthy foods and behaviors to improve health, and healthcare services like cancer treatment and managing mental health conditions. Examples of highest priority interventions in each package are provided based on their potential health impact, cost-effectiveness, and ability to strengthen health systems and provide financial risk protection to populations.
This presentation looks at ways in which governments can set prices, including “cost plus”, value, and the external referencing of prices elsewhere. It looks at the role that competition can play in keeping down prices. In that context it briefly discusses pricing proposals being considered in Malaysia. It makes the case for using HTA to inform pricing decisions.
Adrian Towse
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...Office of Health Economics
The document discusses healthcare spending in Malaysia relative to other countries. It notes that while Malaysia spends around 4% of GDP on healthcare, this is split almost evenly between public and private spending. There are pressures to increase healthcare spending due to an aging population and shift to chronic diseases. While additional investment may pay off through economic and health gains, funding needs to be increased through measures like taxes on tobacco or reducing fossil fuel subsidies. The large public-private divide and high out-of-pocket spending also need to be addressed through more strategic purchasing of healthcare services.
Role of In Vitro Diagnostics in Saudi ArabiaSolidiance
Saudi Arabia’s healthcare system currently relies heavily on government funding, which accounts for 65% healthcare spending in the country. Healthcare trends in Saudi Arabia's, e.g. demographic shifts, high incidence rates of lifestyle related diseases, growing demand for private healthcare services, and strategic investments made by the government have driven demands for in vitro diagnostic (IVD) devices. Solidiance co-developed this exclusive white paper with Kind Abdulaziz Medical City and Abbott Diagnostics, highlighting the contribution, value and future of in vitro diagnostics in Saudi Arabia’s healthcare system. According to the report, the future looks bright for IVD in Saudi Arabia, however it depends on how fast it can be adopted and implemented in order to benefit the government, healthcare players seeking to improve and invest on the sector, and also the people.
The document provides information about the Third International Conference for Improving Use of Medicines (ICIUM2011) which will be held from April 10-14, 2011 in Bibliotheca Alexandrina, Egypt. It discusses the goals of ICIUM conferences which are to improve medicine use and health, recommend evidence-based strategies, identify ways to monitor impacts, and develop a research agenda. The document outlines the conference structure, participating organizations, registration details, and calls for abstract submissions.
This document discusses the Independent Hospital Pricing Authority's (IHPA) work on pricing reforms beyond 2020. Key points include:
1) IHPA sets national efficient prices, develops classification systems, and handles cross-border disputes to promote transparency, value, and efficiency in the public hospital system.
2) IHPA is moving public hospital funding toward an activity-based funding model, with blocks of funding still used in some areas. This has led to a significant slowdown in cost growth.
3) IHPA is developing pricing approaches to incentivize safety, quality and efficiency. This includes not funding episodes involving sentinel events, paying less for episodes complicated by hospital-acquired conditions,
Registries for Medical Devices in Europe Reflection Paper_January 2016Sebastian Gaiser
The document outlines 6 key principles for establishing medical device registries in Europe: 1) Define the scope, 2) Set up proper governance, 3) Establish fair and transparent financing, 4) Ensure collection of quality data and data protection, 5) Make data available and reported, and 6) Guarantee proper education and qualification. It argues that following these principles can improve the quality, acceptability and efficiency of collecting and analyzing registry data to further research and decision making.
OHE Lunchtime Seminar with Associate Professor Paula Lorgelly, Deputy Director, Office of Health Economics
From the Antipodes to the Motherland: reflections on HTA decision makers as budget takers and budget makers
This OECD report, launched on January 10, 2017, systematically reviews strategies put in place by countries to limit ineffective spending and waste. Further information: http://www.oecd.org/health/health-systems/tackling-wasteful-spending-on-health-9789264266414-en.htm.
The Eastern Mediterranean Region has a low density of health workers compared to other WHO regions. While the number of medical schools and density of physicians and nurses has increased in recent decades, it has not kept pace with population growth. There are also imbalances in skill mix and distribution of health workers across countries in the region. Protracted crises have led to out-migration of health workers and violence against healthcare facilities. To address these health workforce challenges, the draft WHO regional framework calls for countries to develop strategic plans, increase investment in education and employment, strengthen collaboration and information systems, and enhance regional cooperation.
The document summarizes the key points of Ireland's Action Plan for Health Research 2009-2013. It outlines the plan's goals to strengthen linkages between health research, services, and the economy. The plan aims to establish national research priorities, infrastructure, and clinical trial networks. It also seeks to improve commercialization, regulation, skills development, and evaluation to help close the gap between existing and potential health outcomes through high-quality, patient-focused research.
Multi-Indication Pricing: Pros, Cons and Applicability to the UKKerry Sheppard
This document discusses multi-indication pricing (MIP), where medicines are priced differently for separate indications. The document examines the pros and cons of MIP compared to uniform pricing across all indications. It also explores international examples of MIP and whether MIP could be implemented in the UK using the Systemic Anti-cancer Therapy dataset to track drug usage by indication. While MIP may allow prices to better reflect clinical value and increase access, ensuring accurate tracking of drug usage by indication presents challenges for implementation in the UK healthcare system.
EuroBioForum 2013 - Day 1 | Pierre MeulienEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Genomics and personalised health in Canada
Dr Pierre Meulien, President and CEO at Genome Canada
=======================================
http://www.eurobioforum.eu
The role of real world data and evidence in building a sustainable & efficien...Office of Health Economics
This presentation defines RWD and RWE in the context of digital health, and looks at potential uses for RWD and RWE. It briefly sets out the current landscape in Malaysia and looks at the challenges in using RWE. In particular, the issues of access, governance and ensuring good quality are considered.
The Impact of Digital Health on Our Everyday Lives eHealth Forum
The document discusses the impact of digital health technologies on everyday lives. It provides examples of how ambient assisted living and remote patient monitoring can help address issues with an aging population and rising healthcare costs. Specifically, it summarizes a European project that used multi-modal sensors and analytics to remotely monitor patients with dementia and improve outcomes. Going forward, it envisions intelligent coaching platforms that provide personalized health advice and support through conversational agents.
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Genome British Colombia, Canada:
Regional Perspectives on Personalized Medicine in British Columbia, Canada
Dr Rachael Ritchie
Director Business Development Genome British Colombia
=======================================
http://www.eurobioforum.eu
This white paper explores how public and private bodies in the UK could work together to accelerate the development and adoption of personalized medicine through strategic alliances. Personalized medicine involves classifying individuals into disease subpopulations to identify who will benefit most from specific treatments. The paper recommends that the UK focus on personalized medicine approaches for several diseases areas, and establish partnerships and initiatives to advance the necessary biomarkers and technologies.
Global HTA and pricing mechanisms
What can we learn about national medicines pricing and procurement?
Led by Janssen UK
Day One, Pop-up University 3, 16.00
The document provides an overview of market opportunities for Finnish health technology companies in Norway. It summarizes Norway's national hospital plan for 2016-2019, which outlines visions and upcoming focus areas in the healthcare sector. Key opportunities for Finnish companies include providing solutions for large hospital projects, emergency services, areas of clinical focus like cardiology and cancer, mental health and substance abuse, technologies that increase patients' role in their own care, and telemedicine for remote areas. The report also introduces the Norwegian healthcare system and governance structure, as well as ongoing procurement processes and a recommended go-to-market model for entering the Norwegian market.
Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014Odyssey Recruitment
This presentation was shown at Opportunity Arabia 11, 2014. It looks at the Saudi Arabian Health Care Sector and the opportunities in this sector for UK businesses. The sector is developing quickly and there are opportunities in all areas but especially high tech medicine, diagnostic equipment, IT and hospital management.
This presentation looks at ways in which governments can set prices, including “cost plus”, value, and the external referencing of prices elsewhere. It looks at the role that competition can play in keeping down prices. In that context it briefly discusses pricing proposals being considered in Malaysia. It makes the case for using HTA to inform pricing decisions.
Adrian Towse
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...Office of Health Economics
The document discusses healthcare spending in Malaysia relative to other countries. It notes that while Malaysia spends around 4% of GDP on healthcare, this is split almost evenly between public and private spending. There are pressures to increase healthcare spending due to an aging population and shift to chronic diseases. While additional investment may pay off through economic and health gains, funding needs to be increased through measures like taxes on tobacco or reducing fossil fuel subsidies. The large public-private divide and high out-of-pocket spending also need to be addressed through more strategic purchasing of healthcare services.
Role of In Vitro Diagnostics in Saudi ArabiaSolidiance
Saudi Arabia’s healthcare system currently relies heavily on government funding, which accounts for 65% healthcare spending in the country. Healthcare trends in Saudi Arabia's, e.g. demographic shifts, high incidence rates of lifestyle related diseases, growing demand for private healthcare services, and strategic investments made by the government have driven demands for in vitro diagnostic (IVD) devices. Solidiance co-developed this exclusive white paper with Kind Abdulaziz Medical City and Abbott Diagnostics, highlighting the contribution, value and future of in vitro diagnostics in Saudi Arabia’s healthcare system. According to the report, the future looks bright for IVD in Saudi Arabia, however it depends on how fast it can be adopted and implemented in order to benefit the government, healthcare players seeking to improve and invest on the sector, and also the people.
The document provides information about the Third International Conference for Improving Use of Medicines (ICIUM2011) which will be held from April 10-14, 2011 in Bibliotheca Alexandrina, Egypt. It discusses the goals of ICIUM conferences which are to improve medicine use and health, recommend evidence-based strategies, identify ways to monitor impacts, and develop a research agenda. The document outlines the conference structure, participating organizations, registration details, and calls for abstract submissions.
This document discusses the Independent Hospital Pricing Authority's (IHPA) work on pricing reforms beyond 2020. Key points include:
1) IHPA sets national efficient prices, develops classification systems, and handles cross-border disputes to promote transparency, value, and efficiency in the public hospital system.
2) IHPA is moving public hospital funding toward an activity-based funding model, with blocks of funding still used in some areas. This has led to a significant slowdown in cost growth.
3) IHPA is developing pricing approaches to incentivize safety, quality and efficiency. This includes not funding episodes involving sentinel events, paying less for episodes complicated by hospital-acquired conditions,
Registries for Medical Devices in Europe Reflection Paper_January 2016Sebastian Gaiser
The document outlines 6 key principles for establishing medical device registries in Europe: 1) Define the scope, 2) Set up proper governance, 3) Establish fair and transparent financing, 4) Ensure collection of quality data and data protection, 5) Make data available and reported, and 6) Guarantee proper education and qualification. It argues that following these principles can improve the quality, acceptability and efficiency of collecting and analyzing registry data to further research and decision making.
OHE Lunchtime Seminar with Associate Professor Paula Lorgelly, Deputy Director, Office of Health Economics
From the Antipodes to the Motherland: reflections on HTA decision makers as budget takers and budget makers
This OECD report, launched on January 10, 2017, systematically reviews strategies put in place by countries to limit ineffective spending and waste. Further information: http://www.oecd.org/health/health-systems/tackling-wasteful-spending-on-health-9789264266414-en.htm.
The Eastern Mediterranean Region has a low density of health workers compared to other WHO regions. While the number of medical schools and density of physicians and nurses has increased in recent decades, it has not kept pace with population growth. There are also imbalances in skill mix and distribution of health workers across countries in the region. Protracted crises have led to out-migration of health workers and violence against healthcare facilities. To address these health workforce challenges, the draft WHO regional framework calls for countries to develop strategic plans, increase investment in education and employment, strengthen collaboration and information systems, and enhance regional cooperation.
The document summarizes the key points of Ireland's Action Plan for Health Research 2009-2013. It outlines the plan's goals to strengthen linkages between health research, services, and the economy. The plan aims to establish national research priorities, infrastructure, and clinical trial networks. It also seeks to improve commercialization, regulation, skills development, and evaluation to help close the gap between existing and potential health outcomes through high-quality, patient-focused research.
Multi-Indication Pricing: Pros, Cons and Applicability to the UKKerry Sheppard
This document discusses multi-indication pricing (MIP), where medicines are priced differently for separate indications. The document examines the pros and cons of MIP compared to uniform pricing across all indications. It also explores international examples of MIP and whether MIP could be implemented in the UK using the Systemic Anti-cancer Therapy dataset to track drug usage by indication. While MIP may allow prices to better reflect clinical value and increase access, ensuring accurate tracking of drug usage by indication presents challenges for implementation in the UK healthcare system.
EuroBioForum 2013 - Day 1 | Pierre MeulienEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Genomics and personalised health in Canada
Dr Pierre Meulien, President and CEO at Genome Canada
=======================================
http://www.eurobioforum.eu
The role of real world data and evidence in building a sustainable & efficien...Office of Health Economics
This presentation defines RWD and RWE in the context of digital health, and looks at potential uses for RWD and RWE. It briefly sets out the current landscape in Malaysia and looks at the challenges in using RWE. In particular, the issues of access, governance and ensuring good quality are considered.
The Impact of Digital Health on Our Everyday Lives eHealth Forum
The document discusses the impact of digital health technologies on everyday lives. It provides examples of how ambient assisted living and remote patient monitoring can help address issues with an aging population and rising healthcare costs. Specifically, it summarizes a European project that used multi-modal sensors and analytics to remotely monitor patients with dementia and improve outcomes. Going forward, it envisions intelligent coaching platforms that provide personalized health advice and support through conversational agents.
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Genome British Colombia, Canada:
Regional Perspectives on Personalized Medicine in British Columbia, Canada
Dr Rachael Ritchie
Director Business Development Genome British Colombia
=======================================
http://www.eurobioforum.eu
This white paper explores how public and private bodies in the UK could work together to accelerate the development and adoption of personalized medicine through strategic alliances. Personalized medicine involves classifying individuals into disease subpopulations to identify who will benefit most from specific treatments. The paper recommends that the UK focus on personalized medicine approaches for several diseases areas, and establish partnerships and initiatives to advance the necessary biomarkers and technologies.
Global HTA and pricing mechanisms
What can we learn about national medicines pricing and procurement?
Led by Janssen UK
Day One, Pop-up University 3, 16.00
The document provides an overview of market opportunities for Finnish health technology companies in Norway. It summarizes Norway's national hospital plan for 2016-2019, which outlines visions and upcoming focus areas in the healthcare sector. Key opportunities for Finnish companies include providing solutions for large hospital projects, emergency services, areas of clinical focus like cardiology and cancer, mental health and substance abuse, technologies that increase patients' role in their own care, and telemedicine for remote areas. The report also introduces the Norwegian healthcare system and governance structure, as well as ongoing procurement processes and a recommended go-to-market model for entering the Norwegian market.
Health Care and Diagnostics Sector Saudi Arabia - Opportunity Arabia 11, 2014Odyssey Recruitment
This presentation was shown at Opportunity Arabia 11, 2014. It looks at the Saudi Arabian Health Care Sector and the opportunities in this sector for UK businesses. The sector is developing quickly and there are opportunities in all areas but especially high tech medicine, diagnostic equipment, IT and hospital management.
EuroBioForum 2013 - Day 1 | Oyvind MelienEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Norway:
Personalised medicine in Norway
Dr Øyvind Melien
Senior Advisor at Norwegian Directorate of Health
=======================================
http://www.eurobioforum.eu
Christina Wanscher presents an introduction to the Danish Healthcare system, healthcare transformation initiatives, National Healthcare IT and Integrated Care.
Details on the presentation found in link:
http://www-01.ibm.com/software/city-operations/curam-research-institute/curam-roundtable/index.html
The document discusses current care guidelines in Finland. It provides background on key organizations involved in developing clinical practice guidelines, including the Finnish Medical Society Duodecim. Guidelines are evidence-based and produced through collaboration between medical societies. Guidelines are available online and aim to improve healthcare quality and ensure equal care. Electronic tools like Terveysportti support accessing guidelines and other medical resources.
ECO 11: Medicines Optimisation in Northern Ireland - Frans van AndelInnovation Agency
Frans introduces the work of the Medicines Optimisation Innovation Centre based in Northern Ireland. He talks about their background; aims and how they achieve them; and current key initiatives. Frans also discusses the ongoing work of MOIC in enabling technology, the pharmaceutical industry, knowledge transfer, training and education, and other key initiatives.
This presentation by the Martin Wenzl (Policy Analyst, OECD Health Division) was made during a workshop on “Regulation and competition in light of digitalisation” held by the OECD in Paris on 31 January 2018. More papers and presentations on the topic can be found out at oe.cd/wrcd.
Performance budgeting & measurement system - Thomas Neby-Baardseng, NorwayOECD Governance
This presentation was made by Thomas Neby-Baardseng, Norway, at the 7th meeting of the Joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held at the OECD Conference Centre, Paris, on 14-15 February 2019
Dr. Colman Casey, Director, Health Innovation HubIMSTA
This document summarizes the establishment and progress of the Health Innovation Hub in Ireland. It discusses the commitment to establish a hub to drive collaboration between healthcare and industry. It provides details on companies selected for the initial demonstrator hub projects and trials conducted. It outlines plans for national hub that would span the entire healthcare system and regions to further support innovation and economic growth through healthcare industry partnerships.
BigInsight seminar on Practical Privacy-Preserving Distributed Statistical Co...Statistisk sentralbyrå
Seminar Monday March 5th 2018 by BigInsight and Statistics Norway: Presentation by Stein Olav Skrøvseth: The national role of the Norwegian Centre for E-health Research and its focus on Health data analytics
"Quality Standards to Quality Assured Indicators: The End-to-End Process", presentation delivered by John Varlow (Director of Information Services - HSCIC) and Nick Baillie (Associate Director, Indicators, Health and Social Care Quality Team, NICE), at the Healthcare Efficiency Through Technology Expo 2013.
An eHealth suite for the support of Primary Health Care.
Athena Triantafyllidi, IT Director at IDIKA explains the developments behind the eGov organisation for Social Security and what led them to be considered one of the leading European examples in implementing a digital reference for all those living in Greece.
Twitter: @idikagr
Strategy For Evidence Based Health ServicesØystein Eiring
The document outlines a collaboration between the Norwegian Knowledge Center for the Health Services and Innlandet Hospital Trust to implement an evidence-based health strategy. It describes challenges to evidence-based practice in Norway like unequal access to knowledge and lack of infrastructure. The strategy proposes core components like developing evidence-based knowledge support systems, training health workers, and creating examples to build awareness and adoption of evidence-based practices. Specific tasks are identified like improving basic resources, educating leaders, developing clinical protocols, and training programs. The goal is to fully integrate evidence-based medicine into the operations and culture of the health trusts.
This document provides an introduction and overview of a hospital project in Mongolia. It discusses the project timeline and goals, including establishing a modern hospital to international standards with advanced technologies. The hospital infrastructure is described as the first in the country to meet European standards, with features like infection prevention systems and an advanced building management system. Clinical services, medical specialties, and a professional team of local and foreign doctors and nurses are outlined. The hospital aims for clinical excellence through practices like evidence-based guidelines. Customer services and partnerships are also summarized.
Should the Norwegian public prenatal care program include an ultrasound scan ...HTAi Bilbao 2012
Should the Norwegian public prenatal care program include an ultrasound scan in the first trimester?
Siv Cathrine Høymork, Hege Wang, Vigdis Lauvrak, Ånen Ringard
Secretariat for the National Council for Priority setting in Health Care
The Norwegian Knowledge Centre for the Health Services
Should the Norwegian public prenatal care program include an ultrasound scan ...HTAi Bilbao 2012
The document discusses whether Norway's public prenatal care program should include an ultrasound scan in the first trimester. An expert committee assessed the proposal and found no documented health benefits, but recognized potential benefits like increased patient satisfaction and detecting Down syndrome. The committee recommended including the additional scan after pilot testing to evaluate the economic and priority setting impacts, justifying that it could improve standards and access without significantly increasing costs. The final decision will be made by Parliament.
The document discusses transparency and oversight of political party financing. It finds that financial contributions to political parties are not fully transparent and are still vulnerable to political and foreign influence. Additionally, financial reports from political parties are not always publicly available or submitted on time according to regulations.
Summary of the OECD expert meeting: Construction Risk Management in Infrastru...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
Using AI led assurance to deliver projects on time and on budget - D. Amratia...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
ECI in Sweden - A. Kadefors, KTH Royal Institute of Technology, Stockholm (SE)OECD Governance
This document discusses different construction project delivery and payment models. It begins by outlining common delivery models like design-bid-build and design-build. It then explains different payment methods that can be used like fixed price, unit prices, and cost-reimbursable. The document also discusses pricing strategies and how they relate to risk transfer between parties. It provides details on collaborative models like early contractor involvement and discusses selecting the optimal contract based on a client's project risks, desired influence, and market conditions.
Building Client Capability to Deliver Megaprojects - J. Denicol, professor at...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
Procurement strategy in major infrastructure: The AS-IS and STEPS - D. Makovš...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
Procurement of major infrastructure projects 2017-22 - B. Hasselgren, Senior ...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
ECI Dutch Experience - A. Chao, Partner, Bird&Bird & J. de Koning, Head of Co...OECD Governance
This document discusses ECI Dutch experience with collaborative contracting. It mentions a McKinsey report from 2018 on collaborative contracting and recent developments in the field. Finally, it provides lessons learned from a project in Amsterdam called Bouwteam De Nieuwe Zijde Noord.
ECI in Sweden - A. Kadefors, KTH Royal Institute of Technology, StockholmOECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
EPEC's perception of market developments - E. Farquharson, Principal Adviser,...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
Geographical scope of the lines in Design and Build - B.Dupuis, Executive Dir...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
Executive Agency of the Dutch Ministry of Infrastructure and Water Management...OECD Governance
Presented at the OECD expert meeting "Construction Risk Management in Infrastructure Procurement: The Loss of Appetite for Fixed-Price Contracts", held on 17 May 2023 at the OECD, Paris and online.
Presentation of OECD Government at a Glance 2023OECD Governance
Paris, 30 June, 2023
Presentation by Elsa Pilichowski, Director for Public Governance, OECD.
The 2023 edition of Government at a Glance provides a comprehensive overview of public governance and public administration practices in OECD Member and partner countries. It includes indicators on trust in public institutions and satisfaction with public services, as well as evidence on good governance practices in areas such as the policy cycle, budgeting, procurement, infrastructure planning and delivery, regulatory governance, digital government and open government data. Finally, it provides information on what resources public institutions use and how they are managed, including public finances, public employment, and human resources management. Government at a Glance allows for cross-country comparisons and helps identify trends, best practices, and areas for improvement in the public sector.
See: https://www.oecd.org/publication/government-at-a-glance/2023/
The Protection and Promotion of Civic Space: Strengthening Alignment with Int...OECD Governance
Infographics from the OECD report "The Protection and Promotion of Civic Space Strengthening Alignment with International Standards and Guidance".
See: https://www.oecd.org/gov/the-protection-and-promotion-of-civic-space-d234e975-en.htm
OECD Publication "Building Financial Resilience
to Climate Impacts. A Framework for Governments to manage the risks of Losses and Damages.
Governments are facing significant climate-related risks from the expected increase in frequency and intensity of cyclones, floods, fires, and other climate-related extreme events. The report Building Financial Resilience to Climate Impacts: A Framework for Governments to Manage the Risks of Losses and Damages provides a strategic framework to help governments, particularly those in emerging market and developing economies, strengthen their capacity to manage the financial implications of climate-related risks. Published in December 2022.
OECD presentation "Strengthening climate and environmental considerations in infrastructure and budget appraisal tools"
by Margaux Lelong and Ana Maria Ruiz during the 9th Meeting of the OECD Paris Collaborative on Green Budgeting held on 17 and 18 of April 2023 in Paris.
OECD presentation "Building Financial Resilience to Climate Impacts. A Framework to Manage the Risks of Losses and Damages" by Andrew Blazey, Stéphane Jacobzone and Titouan Chassagne. Presented during the 9th Meeting of the OECD Paris Collaborative on Green Budgeting held on 17 and 18 of April 2023 in Paris
OECD Presentation "Financial reporting, sustainability information and assurance" by Peter Welch during the 5th Session during the 9th Meeting of the OECD Paris Collaborative on Green Budgeting held on 17 and 18 of April 2023 in Paris
This document summarizes developments in sovereign green bond markets. It discusses approaches to incorporating environmental, social, and governance (ESG) factors into public debt management. Sovereign green bond issuance has grown significantly in both advanced and emerging economies since 2016. Green bonds make up the largest share of the labeled bond market. Major benefits of sovereign green bonds include their positive impact on creditworthiness and alignment with ESG policies. However, issuers also face challenges such as additional costs and complexity of the issuance process. Common leading practices emphasize transparency, collaboration, and commitment to reporting.
Presentation by Rebecca Sachs and Joshua Varcie, analysts in CBO’s Health Analysis Division, at the 13th Annual Conference of the American Society of Health Economists.
Presentation by Julie Topoleski, CBO’s Director of Labor, Income Security, and Long-Term Analysis, at the 16th Annual Meeting of the OECD Working Party of Parliamentary Budget Officials and Independent Fiscal Institutions.
Causes Supporting Charity for Elderly PeopleSERUDS INDIA
Around 52% of the elder populations in India are living in poverty and poor health problems. In this technological world, they became very backward without having any knowledge about technology. So they’re dependent on working hard for their daily earnings, they’re physically very weak. Thus charity organizations are made to help and raise them and also to give them hope to live.
Donate Us:
https://serudsindia.org/supporting-charity-for-elderly-people-india/
#oldagehome, #donateforeldersinkurnool, #donateforelders, #donationforelders, #donateforoldpeople, #donationforoldpeople, #sponsorforelders, #sponsorforoldpeople, #donationforcharity, #charity, #seruds, #kurnool, #donateforoldagehome, #oldagehomedonation
Sponsor a Child for Education & Food.pptxSERUDS INDIA
Every year there are many generous people across the world who wanna help needy children with everything they need. The statistics say that donations worth education and food for more than 500 million children get every year
Donate Us:
https://serudsindia.org/sponsor-a-child-india-2021-kurnool/
#donatefororphan, #donateforhomelesschildren, #childeducation, #ngochildeducation, #donateforeducation, #donatefoodforchildren, #foodforchildren, #donationforchildeducation, #sponsorforpoorchild, #sponsororphanage #sponsororphanchild, #donation, #education, #charity, #educationforchild, #seruds, #kurnool
Disampaikan pada FGD Kepmen Pertahanan tentang Organisasi Profesi JF Analis Pertahanan Negara
Jakarta, 20 Juni 2024
Dr. Tri Widodo W. Utomo, SH. MA.
Deputi Bidang Kajian Kebijakan dan Inovasi Administrasi Negara LAN RI
Advanced health technologies and budgetary implications -- Thomas Baardseng, Norway
1. Norwegian Ministry of Health and Care Services
Norwegian Ministry
of Health and Care Services
Deputy Director General Thomas Baardseng
OECD, Paris, 19. September
Introducing new technologies – the Norwegian
approach
2. Norwegian Ministry of Health and Care Services
Norway – demographics and
organization
• Population of Norway
– 5 millions
• Ministry of Health and Care Services
– Norwegian Directorate of Health
– Norwegian Radiation Protection Authority
– Norwegian Institute for Public Health
– Norwegian Medicines Agency
– Another five agencies
• Health Care Services
– Primary health care in 400+ municipalities
– Specialist health care
• 4 Regional Health Authorities with ownership of hospitals and
other enterprises
3. Norwegian Ministry of Health and Care Services
An eternal challenge - The expectation gap
0
5
10
15
20
25
1 2 3 4 5 6
New technologies
Expectations
Economic reality
4. Norwegian Ministry of Health and Care Services
The national system for managed
introduction
• Systematic use of health technology
assessments are important:
• To improve patient safety
• To ensure equal access to new effective and
cost-effective methods and drugs
• To ensure that ineffective and/or harmful
methods and drugs are not introduced
• To provide a decision-making platform for
priority setting based on such assessments
• To ensure rational use of public money
5. Norwegian Ministry of Health and Care Services
Three categories of HTAs
5
Mini Health
Technology
Assessment (Mini-
HTA)
Single Technology
Assessment (STA)
Full Health
Technology
Assessment (Full
HTA)
• Limited assessment at hospital level. Published in national
database to share knowledge
• Used for medical devices, procedures, organization
• Performed by clinicians and supporting units
• Assessment at national level focused on a single health technology
• Medicines: Norwegian Medicines Agency
• Other technologies: Norwegian Knowledge Centre
• Broad assessments at national level
• Norwegian Knowledge Centre for the Health Services
6. Norwegian Ministry of Health and Care Services
The overall objective
• Managed introduction to meet health needs and sustainability
– To ensure that new technologies meet health needs and sustainability of the health care system, managed
introduction and prioritization offer important tools
6
New health technologies
Managed introduction and
prioritization
Health needs and sustainable
health care